Telitacicept in refractory juvenile generalized myasthenia gravis: a case report and collective analysis
BackgroundRefractory or corticosteroid-dependent juvenile generalized myasthenia gravis (gMG) remains a clinical challenge, given the scarcity of available regimens and prominent corticosteroid-related adverse effects. Telitacicept, a dual inhibitor of…